Zoe M. Weinstein, MD, MS
Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
General Internal Medicine

MD, University of California San Francisco
MS, Boston University School of Public Health
BA, Columbia University



Zoe M. Weinstein, MD, MS, is a graduate of Boston University’s Addiction Medicine Fellowship and board certified in Internal Medicine and Addiction Medicine. She has been the Director of Boston Medical Center’s interdisciplinary addiction consult service since July 2016. She has been NIDA grant funded as a co-investigator on multiple studies to deliver training and technical assistance to interdisciplinary provider teams (physicians, nurse practitioners, social workers, addiction counselors and recovery coaches) to expand treatment for opioid use disorder among hospitalized patients in New York City public hospitals as well as hospitals in Massachusetts as part of the HEALing Communities Study. She is currently site-PI of two NIDA Clinical Trial Network studies focused on inpatient addiction care. Her clinical and research work are also focused on long-term Office-Based Addiction Treatment (OBAT) with buprenorphine. She currently serves as Associate Director of Boston University’s Addiction Medicine Fellowship Program, a board member of AMERSA and is a site medical director of a local methadone clinic.

Diversity, Equity, Inclusion and Accessibility

As a graduate of BU's Women's Leadership program, I am dedicated to serving as a career mentor and peer mentor to trainees and faculty who identify as women. As the director of the Addiction Consult Service, I am dedicated to equity and diversity in the hiring process as well as retaining and promoting staff from diverse backgrounds, especially staff who identify as BIPOC, LGBTQIA+,and those with lived experience with substance use. As one of the Associate Program Directors for the Addiction Medicine Fellowship, I have collaborated with the rest of the fellowship leadership on completely revising the interview process to a structured interview to increase diversity, equity and accessibility of the fellowship program and increase the diversity of the addiction workforce. This has been done in partnership with the Inclusion Diversity & Equity In Addiction medicine, Addiction health professions, and Addiction research (IDEAAA) Program and the Recognizing and Eliminating Disparities in Addiction through Culturally-informed Healthcare (REACH Program).
I am personally committed to continuing to explore and address my own biases, including participating in Boston University's Bias Reduction in Internal Medicine training, the Conversations on Race/Equity discussion series, and the DOM Reads book club.

Faculty
Boston University Chobanian & Avedisian School of Medicine
Medicine
Clinical Addiction Research and Education Unit




The National Drug Abuse Clinical Trials Network: New England Consortium Node
08/01/2023 - 02/28/2025 (Subcontract PI)
PI: Zoe M. Weinstein, MD, MS
Yale University School of Medicine NIH NIDA
5UG1DA015831-22

NorthStar Node of the Clinical Trials Network--0098A
03/01/2022 - 02/28/2025 (Subcontract PI)
PI: Zoe M. Weinstein, MD, MS
Hennepin Healthcare Research Institute NIH NIDA

NorthStar Node of the Clinical Trials Network--0098B
03/01/2022 - 02/28/2025 (Subcontract PI)
PI: Zoe M. Weinstein, MD, MS
Hennepin Healthcare Research Institute NIH NIDA

NIDA CTN-0131: Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment -A Randomized Pragmatic Hybrid Effectiveness/Implementation Trial
08/01/2023 - 02/29/2024 (Subcontract PI)
PI: Zoe M. Weinstein, MD, MS
Yale University School of Medicine NIH NIDA

Health Systems Node of the NIDA Clinical Trials Network (Primary Care Opioid Use Disorders Treatment (PROUD) Trial -Dissemination Activities 1)
09/01/2022 - 02/29/2024 (Subcontract PI)
PI: Zoe M. Weinstein, MD, MS
Kaiser Permanente NIH NIDA
3UG1DA040314-08S1

Preventing Bacterial and Viral Infections Among Injection Drug users
09/09/2016 - 04/30/2020 (Multi-PI)
PI: Zoe M. Weinstein, MD, MS
Trustees of Boston University,CRC NIH NIDA

Next Generation Award for Adolescent Substance Use Prevention-Zoe Weinstein
07/01/2014 - 06/30/2015 (PI)
American Board of Addiction Medicine Foundation


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Davoust M, Bazzi AR, Blakemore S, Blodgett J, Cheng A, Fielman S, Magane KM, Theisen J, Saitz R, Ventura AS, Weinstein ZM. Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study. Addict Sci Clin Pract. 2025 Mar 04; 20(1):21. PMID: 40033433; PMCID: PMC11877703; DOI: 10.1186/s13722-025-00536-3;
     
  2. Bart G, Barth KS, Baukol P, Enns E, Ghitza UE, Harris J, Jelstrom E, Liebschutz JM, Magane KM, Voronca D, Weinstein ZM, Korthuis PT. Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder. Addict Sci Clin Pract. 2024 Dec 02; 19(1):91. PMID: 39623502; PMCID: PMC11610182; DOI: 10.1186/s13722-024-00510-5;
     
  3. Shearer R, Englander H, Hagedorn H, Fawole A, Laes J, Titus H, Patten A, Oot E, Appleton N, Fitzpatrick A, Kibben R, Fernando J, McNeely J, Gustafson D, Krawczyk N, Weinstein Z, Baukol P, Ghitza U, Siegler T, Bart G, Bazzi A. Hospital Provider's Perspectives on MOUD Initiation and Continuation After Inpatient Discharge. J Gen Intern Med. 2024 Nov 25.View Related Profiles. PMID: 39586949
     
  4. Weinstein ZM, Yu O, Wartko PD, Samet JH, Bobb JF, Braciszewski JM, Arnsten JH, Murphy MT, Horigian VE, Stotts AL, Beers D, Bradley K. Does implementation of office based addiction treatment by a nurse care manager increase the duration of OUD treatment in primary care? A secondary analysis of the PROUD randomized control trial. Drug Alcohol Depend. 2024 Dec 01; 265:112497.View Related Profiles. PMID: 39550823; PMCID: PMC11608535; DOI: 10.1016/j.drugalcdep.2024.112497;
     
  5. Rosenmoss S, LaRochelle M, Bearnot B, Weinstein Z, So-Armah K, Moyo P, Yan S, Walley AY, Kimmel SD. Racial and Ethnic Disparities in Referral Rejection From Postacute Care Facilities Among People With Opioid Use Disorder in Massachusetts. J Addict Med. 2025 Mar-Apr 01; 19(2):165-171.View Related Profiles. PMID: 39514897; DOI: 10.1097/ADM.0000000000001390;
     
  6. Rozansky H, Christine PJ, Younkin M, Fox JM, Weinstein ZM, Suarez S, Stewart J, Farrell N, Taylor JL. Addiction consult service involvement in PrEP and PEP delivery for patients who inject drugs admitted to an urban essential hospital. Addict Sci Clin Pract. 2024 Nov 04; 19(1):77.View Related Profiles. PMID: 39497126; PMCID: PMC11533369; DOI: 10.1186/s13722-024-00502-5;
     
  7. Shearer R, Hagedorn H, Englander H, Siegler T, Kibben R, Fawole A, Patten A, Fitzpatrick A, Laes J, Fernando J, Appleton N, Oot E, Titus H, Krawczyk N, Weinstein Z, McNeely J, Baukol P, Ghitza U, Gustafson D, Bart G, Bazzi A. Barriers and facilitators to implementing treatment for opioid use disorder in community hospitals. J Subst Use Addict Treat. 2024 Dec; 167:209520.View Related Profiles. PMID: 39265915; PMCID: PMC11749276; DOI: 10.1016/j.josat.2024.209520;
      Article has an altmetric score of 1
  8. McNeely J, Wang SS, Rostam Abadi Y, Barron C, Billings J, Tarpey T, Fernando J, Appleton N, Fawole A, Mazumdar M, Weinstein ZM, Kalyanaraman Marcello R, Dolle J, Cooke C, Siddiqui S, King C. Addiction Consultation Services for Opioid Use Disorder Treatment Initiation and Engagement: A Randomized Clinical Trial. JAMA Intern Med. 2024 Sep 01; 184(9):1106-1115. PMID: 39073796; PMCID: PMC11287446; DOI: 10.1001/jamainternmed.2024.3422;
      Article has an altmetric score of 129
  9. Weinstein ZM, Magane KM, Lodi S, Ventura AS, Bazzi AR, Blodgett J, Fielman S, Davoust M, Shea MG, Chen CA, Cheng A, Theisen J, Blakemore S, Saitz R. The Impact of COVID-19 on Substance Use and Related Consequences Among Patients in Office-based Opioid Use Disorder Treatment. J Addict Med. 2025 Jan-Feb 01; 19(1):12-19.View Related Profiles. PMID: 39101572; PMCID: PMC11790372; DOI: 10.1097/ADM.0000000000001367;
      Article has an altmetric score of 4
  10. Bobb JF, Idu AE, Qiu H, Yu O, Boudreau DM, Wartko PD, Matthews AG, McCormack J, Lee AK, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Northrup TF, Braciszewski JM, Murphy MT, Arnsten JH, Cunningham CO, Horigian VE, Szapocznik J, Glass JE, Caldeiro RM, Tsui JI, Burganowski RP, Weinstein ZM, Murphy SM, Hyun N, Bradley KA. Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial. Drug Alcohol Depend. 2024 Aug 01; 261:111350.View Related Profiles. PMID: 38875880; PMCID: PMC11281026; DOI: 10.1016/j.drugalcdep.2024.111350;
     
Showing 10 of 57 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 57 publications over 10 distinct years, with a maximum of 11 publications in 2024

YearPublications
20165
20174
20182
20196
20203
202110
202210
20235
202411
20251

Note: X.com has changed/limited the ability to embed tweets directly in external sites and we are investigating ways to restore that functionality in BU Profiles. In the meantime we are displaying a link to your x.com profile in the Websites section above.

How the U.S. is sabotaging its best tools to prevent deaths in the opioid epidemic

STAT 3/5/2024

BMC Pilots Training Program to Improve Post-Acute Care for Patients with Substance Use Disorder

HealthCity 5/17/2022

Boston Sunday Review: Dr. Zoe Weinstein, BMC

98.5 News 12/2/2018

Addiction treatment policies pose risk to incarcerated patients

The Boston Globe 3/31/2018

2022 Boston University School of Medicine: Distinguished Faculty of the Month - February
2021 The Association for Multidisciplinary Education and Research in Substance use and Addiction: Best Workshop Award
2017 Boston University School of Public Health: Delta Omega Honors Society
2015 American Society of Addiction Medicine : Ruth Fox Scholarship
2015 The Association for Multidisciplinary Education and Research in Substance use and Addiction: Conference Travel Award
2014 American Society of Addiction Medicine : Next Generation Award
2014 Boston Medical Center: Resident Advocacy Award
2014 Boston Medical Center: John Noble Scholarship
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

substance use; primary care; buprenorphine; addiction consult service

Zoe Weinstein MD, MS has mentored medical students in the summer research program as well as longitudinally, resulting in national oral presentations and multiple publications including at least one first author publication. She also mentors residents and fellows in research projects which have resulted in national oral presentations and publications. She actively mentors residents and fellows who are interested in careers in primary care and addiction medicine.

Available to Mentor as: (Review Mentor Role Definitions):
  • Career Mentor
  • Education Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

617.414.7399
Download vCard

Weinstein's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (172) concept(s)
_
Media Mentions
_
Co-Authors
See all (69) people
_
Similar People
See all (60) people
_
Same Department
Search Department